Editorial Expression of Concern: Therapeutic potential of mesenchymal stem/stromal cells (MSCs)-based cell therapy for inflammatory bowel diseases (IBD) therapy

• Mohamed J. Saadh,
• Maria V. Mikhailova,
• Soheil Rasoolzadegan,
• Mojgan Falaki,
• Roozbeh Akhavanfar,
• José Luis Arias Gonzáles,
• Amir Rigi,
• Bahman Abedi Kiasari

Affiliations

Mohamed J. Saadh

Department of Basic Sciences, Faculty of Pharmacy, Middle East University

Maria V. Mikhailova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Soheil Rasoolzadegan

Department of Surgery, School of Medicine, Shahid Beheshti University of Medical Sciences

Mojgan Falaki

Department of Internal Medicine, Shahid Beheshti University of Medical Sciences

Roozbeh Akhavanfar

School of Medicine, Isfahan University of Medical Sciences

José Luis Arias Gonzáles

Pontifcia Universidad Católica del Perú

Amir Rigi

Department of Nursing, Young Researchers and Elite Club, Zahedan Branch, Azad University

Bahman Abedi Kiasari

Virology Department, Faculty of Veterinary Medicine, The University of Tehran